A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people.

Researchers sought to determine trends and future patterns for liver, pancreatic, colorectal, stomach, and esophageal cancers in the US.

David B. Zhen, MD, discusses the results of the phase 3 CheckMate 649 trial in patients with advanced gastric cancer, ...

Researchers investigated immune-related adverse effects and characteristics that may predict their incidence in patients receiving ICIs for gastrointestinal cancers.

Men with prostate cancer are living longer than ever, and our goal is to reduce the risk of late toxicities, such as difficulty urinating or rectal bleeding, that can impact a patient’s quality of ...

Aspirin reduced recurrence by 50% in PIK3CA-mutated colorectal cancer, the DCISionRT test earned FDA breakthrough status for predicting radiotherapy benefit in DCIS, and nivolumab plus chemotherapy ...

St. Luke's Hospital is using artificial intelligence (AI) technology that can help doctors find early signs of Colon Cancer.

Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified ...

In resectable, locally advanced esophageal squamous cell carcinoma, neoadjuvant Tyvyt plus chemoradiotherapy led to an ...

Scientific evidence shows that eating high-fibre foods, like pulses, can reduce the risk of bowel cancer. Eating pulses can also help reduce the risk of weight gain, overweight and obesity - doing so ...

An investigational blood test can detect colorectal cancer (CRC) in patients at average risk of CRC, a study suggests.